pimonidazole has been researched along with almokalant in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blomgren, B; Danielsson, BR; Dillner, B; Johansson, A; Sköld, AC | 1 |
1 other study(ies) available for pimonidazole and almokalant
Article | Year |
---|---|
Teratogenicity by the hERG potassium channel blocking drug almokalant: use of hypoxia marker gives evidence for a hypoxia-related mechanism mediated via embryonic arrhythmia.
Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Arrhythmias, Cardiac; Cation Transport Proteins; Dose-Response Relationship, Drug; Ether-A-Go-Go Potassium Channels; Female; Fetal Hypoxia; Image Processing, Computer-Assisted; Injections, Intravenous; Nitroimidazoles; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Pregnancy; Propanolamines; Rats; Rats, Sprague-Dawley; Teratogens; Videotape Recording | 2003 |